ABILIFY MAINTENA is a long-acting aripiprazole formulation with 4-week dosing intervals indicated for the treatment of schizophrenia and maintenance monotherapy of bipolar I disorder in adults. In contrast, aripiprazole injection (9.75 mg per vial) is a short-acting formulation indicated for agitation ...
With the Abilify Maintena Copay Card ,you may pay as little as $10 a month. The Abilify Maintena Copay CardCopay Card helps you save money on prescriptions with an annual maximum benefit of $8,000 and a monthly $1,400 maximum.
Generic Name: Aripiprazole · Brand Name: Abilify Asimtufii, Abilify, Abilify Maintena, Abilify MyCite, Aristada, Aristada Initio Terms & Conditions Contact Shipping
ABILIFY MAINTENA has been evaluated for safety in 2,188 adult patients in clinical trials in schizophrenia, with approximately 2,646 patient-years of exposure to ABILIFY MAINTENA. A total of 1,230 patients were treated with ABILIFY MAINTENA for at least 180 days (at least 7 consecutive injection...
1. (2002) "Product Information. Abilify (aripiprazole)." Bristol-Myers Squibb 2. Cerner Multum, Inc. "UK Summary of Product Characteristics." 3. Cerner Multum, Inc. "Australian Product Information." 4. (2013) "Product Information. Abilify Maintena (aripiprazole)." Otsuka American Pharmaceuticals...
1. (2002) "Product Information. Abilify (aripiprazole)." Bristol-Myers Squibb 2. Cerner Multum, Inc. "UK Summary of Product Characteristics." 3. Cerner Multum, Inc. "Australian Product Information." 4. (2013) "Product Information. Abilify Maintena (aripiprazole)." Otsuka American Pharmaceuticals...